Product Wiki · Recalls · EU Safety Gate (RAPEX)

Al Fakher Molasses — recall A12/1808/13

EU Safety Gate (RAPEX) · Germany · 2013-12-13 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/1808/13
Date of alert
2013-12-13
Country / jurisdiction
Germany
Risk level
Serious risk
Risk type
Chemical
Brand
Al Fakher
Product category
Other - -
Product type
Molasses tobacco
Reported risk: Das Produkt enthält 46,7 Gewichtsprozent Trockenmasse des Feuchthaltemittels Glycerin und überschreitet damit den in den nationalen Rechtsvorschriften festgelegten Höchstwert von 5 %. Das Produkt entspricht nicht den einschlägigen nationalen Rechtsvorschriften.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Other
Category of measure
Import rejected at border
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Al Fakher Molasses

Risk Description (original English): The product containes 46.7 % by weight of dry matter of the humectant glycerin exceeding the maximum permissible level of 5 % laid down in the national legislation.The product does not comply with the relevant national legislaton.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/90722

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.